Background illustration for clinical trials search

Paid Clinical Trials Portland

Discover 928 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Portland OR, Reno NV, Sacramento CA, Vallejo CA,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase 3, Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Portland OR, Tualatin OR, Vancouver WA, Issaquah WA,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase 3, Recruiting
Active & Responsive

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

for
Endometrial Cancer
Location: Portland OR, Eugene OR, San Francisco CA, La Jolla CA,
Sponsor: Faeth Therapeutics

Sex: Female

Age: 18+

Code: NCT06463028

Phase 2, Recruiting
Active & Responsive

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

for
Psoriasis, Overweight or Obesity
Location: Portland OR, Bellevue WA, Reno NV, Fremont CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06857942

Phase 4, Recruiting
Active & Responsive

TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)

for
Alcohol Use Disorder, Opioid Use Disorder
Location: Portland OR
Sponsor: Washington State University

Sex: All

Age: 18+

Code: NCT07171359

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Portland OR, Seattle WA, San Francisco CA, Stanford CA,
Sponsor: Massive Bio, Inc.

Sex: All

Age: 0+

Code: NCT03452774

Recruiting
Active & Responsive

Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

for
Solid Tumor
Location: Portland OR, Stanford CA, Santa Monica CA,
Sponsor: Alyssum Therapeutics

Sex: All

Age: 18+

Code: NCT06234098

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

for
Alzheimer's Disease
Location: Portland OR, Richmond, Kelowna, Redlands CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 60 - 70+

Code: NCT06976216

Phase 3, Recruiting
Active & Responsive

RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: Portland OR, San Francisco CA, Draper UT, Orem UT,
Sponsor: Reunion Neuroscience Inc

Sex: All

Age: 18 - 70+

Code: NCT07489651

Phase 2, Recruiting
Active & Responsive

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

for
Depressive Disorder, Major
Location: Portland OR, Bellevue WA, Surrey, Richmond, Kelowna,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07412756

Phase 3, Recruiting
Active & Responsive

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

for
Lichen Planopilaris
Location: Portland OR, Mill Creek WA, Sacramento CA, Oakland CA,
Sponsor: Priovant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07532603

Phase 2, Phase 3, Recruiting
Active & Responsive

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

for
ADHD
Location: Portland OR, Everett WA, Walnut Creek CA, Provo UT,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 12 - 17

Code: NCT07717892

Phase 3, Recruiting
Active & Responsive

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

for
ADHD
Location: Portland OR, Everett WA, Walnut Creek CA, Provo UT,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 6 - 11

Code: NCT07717879

Phase 3, Recruiting
Active & Responsive

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Portland OR, Clackamas OR, Hillsboro OR, Albany OR,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222800

Phase 3, Recruiting
Active & Responsive

Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

for
Contraception
Location: Portland OR, Seattle WA, San Jose CA, Salt Lake City UT,
Sponsor: University of Utah

Sex: Female

Age: 16 - 35

Code: NCT05444582

Recruiting
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Portland OR, Burlington WA, Spokane WA, Sacramento CA,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07440225

Phase 2, Phase 3, Recruiting
Active & Responsive

CAN1012 in Pre-Malignant DCIS and LCIS

for
Ductal Carcinoma in Situ, Lobular Carcinoma in Situ
Location: Portland OR
Sponsor: Providence Health & Services

Sex: All

Age: 18+

Code: NCT07408856

Phase 1, Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

for
Breast Neoplasms
Location: Portland OR, Surrey, Fullerton CA, Denver CO, Aurora CO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312176

Phase 3, Recruiting
Active & Responsive

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Portland OR, Clackamas OR, Oregon City OR, Newberg OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05136196

Phase 2, Recruiting
Active & Responsive

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Portland OR, Newberg OR, Missoula MT, Kalispell MT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT04671667

Phase 2, Recruiting